| Item Type | Name |
|
Academic Article
|
Mouse models of human AML accurately predict chemotherapy response.
|
|
Academic Article
|
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.
|
|
Academic Article
|
The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.
|
|
Academic Article
|
Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity.
|
|
Academic Article
|
Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.
|
|
Academic Article
|
Replication-dependent irreversible topoisomerase 1 poisoning is responsible for FdUMP[10] anti-leukemic activity.
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Leukemia, Monocytic, Acute
|
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
|
Concept
|
Leukemia, Promyelocytic, Acute
|
|
Concept
|
Leukemia
|
|
Concept
|
Leukemia, Myeloid
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Academic Article
|
Animal models of leukemia: any closer to the real thing?
|
|
Academic Article
|
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
|
|
Academic Article
|
Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).
|
|
Academic Article
|
The poison oligonucleotide F10 is highly effective against acute lymphoblastic leukemia while sparing normal hematopoietic cells.
|
|
Academic Article
|
Acute myeloid leukemia and myelodysplastic syndromes in older adults.
|
|
Academic Article
|
The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).
|
|
Academic Article
|
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.
|
|
Academic Article
|
The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
|
|
Academic Article
|
Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway.
|
|
Academic Article
|
Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.
|
|
Academic Article
|
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly.
|
|
Academic Article
|
Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
|
|
Academic Article
|
Effect of Intensive Chemotherapy on Physical, Cognitive, and Emotional Health of Older Adults with Acute Myeloid Leukemia.
|
|
Academic Article
|
In vitro and in vivo assessment of direct effects of simulated solar and galactic cosmic radiation on human hematopoietic stem/progenitor cells.
|
|
Grant
|
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
|
|
Grant
|
Metabolic contribution to cell viability and therapy resistance in the acute
|
|
Academic Article
|
The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
|
|
Academic Article
|
Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit.
|
|
Academic Article
|
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
|
|
Academic Article
|
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity.
|
|
Academic Article
|
Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia.
|
|
Academic Article
|
Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.
|